All articles by Andy Extance – Page 8
-
Business
Landmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
Business
Building resilience to climate threats
As extreme weather events become more frequent, chemical and pharmaceutical producers are taking steps to fend them off in future
-
Research
Genentech antibiotic quells resistance
Modified arylomycin combines high potency with new mechanism of action
-
Research
Atomic Eiffel tower looms over quantum computing landscape
Many-atom arrays may become ideal quantum simulators for chemical systems
-
Business
Businesses use blockchain to take on trustlessness
Big companies are looking to blockchain technology to track transactions, finds Andy Extance, while upstarts exploit its cryptocurrency origins
-
Research
MOF turns ‘crumple zone’ weakness into strength
Enhanced water stability improves chances of using materials to adsorb toxic contaminants in gas masks
-
Business
Vaccine scandal and heart drug recall show China’s pharma struggles
Fifteen arrests amid evidence of bribery related to vaccines, despite new standards and penalties for fraud
-
News
Indian institute investigates nanoscientists for indiscriminate image manipulation
Four new retractions bring the total for Rashmi Madhuri and Prashant Sharma up to 14, with at least another 50 papers potentially affected
-
Feature
The chemistry of synapses
Scientists are decoding the brain’s exquisite molecular machinery – but there is still a long way to go, finds Andy Extance
-
News
New chemistry enables UK negative carbon dioxide emissions pilot
Carbon capture is back at Drax, thanks to more energy efficient absorption technology
-
Business
US sanctions threaten Iran–Europe petrochemical ties
Companies review their options after Trump administration’s withdrawal from nuclear deal
-
Research
Brain chemistry hints at how obesity impairs antidepressants
Histamine released in response to obesity or bacterial toxins prevents benefits from SSRIs – and that drugs that target these inflammatory signals may restore them
-
Research
‘Cyborg ribosome’ reads polystyrene message to create catalyst
A simplified artificial molecular machine with a useful catalyst product hints at the potential of synthetic systems
-
Business
Novartis’ $8.7bn AveXis deal shows gene therapy appeal
Acquisition indicates the value of potentially permanent cures for inherited diseases
-
Research
New AFM tip reopens hydrogen bond imaging debate
Putting rigid copper oxide on probe prevents artefacts – but what is it actually measuring?
-
Feature
Step-by-step synthesis of DNA
Andy Extance discovers how scientists are delivering the extremely accurate DNA chemistry and biochemistry needed to make genes – and even genomes
-
Research
Optogenetic control puts biosynthesis into – and out of – the spotlight
Using light to switch which enzymes brewer’s yeast produces boosts concentrations of biofuel candidate isobutanol fivefold.
-
Research
Beer engineered in pursuit of hoppiness
Crispr-augmented brewer’s yeast produces flavour molecules, enabling hoppy beer without adding extra hops
-
News
Brexit analysis predicts chemical industry contraction
UK government forced to publish briefing that suggests production will fall by up to 16%
-
Research
Boron clusters turn titanium oxide to the dark side
Titanium-tipped ‘hedgehog’ molecules become a robust – and black – high-performance electronic material